NOVOCURE LTD (NVCR) — insider trading
Health Care · NASDAQ
NOVOCURE LTD (NVCR) has 30 reported SEC Form 4 insider transactions in our data, including 8 open-market sales among the most recent 30 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Danziger Asaf | Director | Grant / award / vesting | 268 | $11.15 | $3.0K | Form 4 |
| 2026-06-30 | Ben Arye Barak | Officer (General Counsel) | Grant / award / vesting | 1,299 | $11.15 | $14.5K | Form 4 |
| 2026-06-30 | Leonard Frank X | Officer (Chief Executive Officer) | Grant / award / vesting | 1,905 | $11.15 | $21.2K | Form 4 |
| 2026-06-30 | Puri Michal Nath | Officer (Chief Human Resources Officer) | Grant / award / vesting | 1,905 | $11.15 | $21.2K | Form 4 |
| 2026-06-04 | Leonard Frank X | Officer (Chief Executive Officer) | Open-market sale | 34,273 | $17.93 | $614.6K | Form 4 |
| 2026-06-03 | VERNON W ANTHONY | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | VERNON W ANTHONY | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | Madden Martin J. | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | Madden Martin J. | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | Hung David | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | Hung David | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | HILLEMAN JERYL L | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | HILLEMAN JERYL L | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | Scannell Timothy J | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | Scannell Timothy J | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | Ocean Allyson J | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | Ocean Allyson J | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | Stafford Kristin | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | Stafford Kristin | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-03 | LEUNG GABRIEL | Director | Grant / award / vesting (derivative) | 16,999 | — | $0 | Form 4 |
| 2026-06-03 | LEUNG GABRIEL | Director | Grant / award / vesting | 11,610 | — | $0 | Form 4 |
| 2026-06-02 | Hung David | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | VERNON W ANTHONY | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | HILLEMAN JERYL L | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | Scannell Timothy J | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | Ocean Allyson J | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | Stafford Kristin | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-06-02 | LEUNG GABRIEL | Director | Open-market sale | 2,945 | $15.77 | $46.4K | Form 4 |
| 2026-04-28 | VERNON W ANTHONY | Director | Option exercise / conversion (derivative) | 21,500 | — | $0 | Form 4 |
| 2026-04-28 | VERNON W ANTHONY | Director | Option exercise / conversion | 21,500 | $11.39 | $244.9K | Form 4 |
Ask the chat about NVCR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NOVOCURE LTD (NVCR).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.